Lucida Medical

Pi™ (Prostate Intelligence™) was featured on BBC News! We're extremely proud to see PI being used within the NHS, helping to transform prostate cancer diagnosis with AI. The whole 10min film on prostate cancer starts at 30:05 lnkd.in/e6CNnmYw (Segment on Pi from 33:26)

Dr Olly Hulson, Consultant Radiologist at Leeds Teaching Hospitals NHS Trust, explains how Pi™ could help identify the most clinically significant prostate cancers, and support a future same-day pathway from scan to biopsy. 🎥 youtube.com/watch?v=NSYib5…

Prostate cancer is the most common cancer in UK men, yet half of cases are diagnosed too late. As part of the national #SBRIHealthcare programme, we're working with @GM_Cancer to deploy Pi™ to help radiologists detect urgent cases faster. 🔗 lucidamedical.com/lucida-medical…

At #BAUS2025, Prof @nikhilvasdevuro led a multi-centre study using Lucida Medical AI to identify EPE from MRI and clinical data, without radiologist input. High sensitivity and NPV suggest AI could support surgical planning. 🔗 poster.baus.org.uk/baus/2025/baus…

Health system spends nearly $7 million on AI to boost prostate MRI performance. @quibimbiomarker @LucidaMedical @SBRIHealthcare @NHS ow.ly/lfvv50WoBzt

@sbrihealthcare funds implementation of @LucidaMedical AI tool for diagnosis of prostate cancer ukauthority.com/articles/sbri-… #NHS #medtech #AI #Cancer @HealthInnovNetwork @AACinnovation

Lucida Medical has been awarded £2.25M by SBRI Healthcare to deploy its AI tool, Prostate Intelligence (Pi™), in up to 15 NHS hospitals. 🔗lucidamedical.com/lucida-medical…

A compelling story in @theipaper shows how AI is improving cancer diagnosis in the NHS. Lucida Medical is featured for supporting prostate cancer detection. Dr Antony Rix, CEO: “We’ve trained AI to tell the difference between ‘nothing to worry about’ and ‘we need to act’.”

Our new logo tells a story. Two Ls form a star, symbolising clarity, direction and purpose. It reflects our mission to guide healthcare professionals through the complexity of prostate cancer care with confidence and precision. More than a mark, it’s a signal of who we are.

Great first day at #BAUS25 in Manchester. 📍 We’re at Booth E20 sharing how our AI supports prostate cancer diagnostics. Come say hello. We're here for two more days. #ProstateCancer #MedicalInnovation

🚀Big news! Lucida Medical has refreshed its brand identity, reinforcing our commitment to AI-powered prostate cancer care. This transformation strengthens our dedication to innovation and excellence in prostate cancer care. 🔗Learn more: lucidamedical.com/new-brand-iden…

What will the role of the GU radiologist look like in 2030? Join our Co-founder Prof. Evis Sala at the ESUR MRI Prostate Teaching Course, 12–14 June in Cambridge. Don’t miss her talk on Saturday 14 June at 17:10: “The GU Radiologist in 2030”. #ProstateCancer #Radiology #ESUR

𝐓𝐡𝐞 𝐜𝐨𝐮𝐧𝐭𝐝𝐨𝐰𝐧 𝐢𝐬 𝐨𝐧! The anticipation is building as we approach a major milestone for Lucida Medical. Our journey in advancing the prostate cancer pathway is about to reach an exciting new phase. Stay with us. The reveal is almost here!

We’re heading to #UKIO2025 in Liverpool, 2–4 June! Want to talk AI, imaging, or prostate cancer care? Book a meeting with our CEO, Dr Antony Rix: outlook.office.com/book/UKIO2025@…

Lucida Medical is entering a new chapter, building on the same mission: advancing the prostate cancer pathway. We’re growing, innovating, and ready to show what’s next. Stay tuned!

We had a great time at #BSUR2025 last week! It was good to see so many of you at our booth and at the symposium with Lucida Medical’s CEO, Dr Antony Rix. Thanks to everyone who stopped by, we enjoyed some really insightful conversations!

Proud to join @PCR_News in championing prostate cancer screening through the #ProactiveForYourProstate campaign. Together, we’re advocating for early detection so we can save thousands of lives each year. Join us and help make screening a reality👉 mailchi.mp/pcr.org.uk/pro…